Literature DB >> 17030851

Human papillomaviruses target the double-stranded RNA protein kinase pathway.

Christy M Hebner1, Regina Wilson1, Janet Rader2, Miri Bidder2, Laimonis A Laimins1.   

Abstract

The double-stranded RNA protein kinase (PKR) pathway plays a vital role in the innate immune response to viral infection. Activation of PKR following virus entry can lead to a shutdown in translation, thereby inhibiting viral protein synthesis and replication. Little is currently known about whether human papillomaviruses (HPVs) modulate PKR expression and activity. In this study, normal human foreskin keratinocytes (NHKs) transfected stably with the HPV 31 or 16 genomes and cell lines expressing the HPV 16 E6 and E7 oncoproteins were used to examine effects on the PKR pathway. HPV gene products were found to modulate PKR phosphorylation, activity and localization. The levels of total PKR protein were reduced modestly in cells that maintained HPV 16 or 31 episomes through a reduction in PKR transcription. However, levels of phosphorylated PKR were decreased 4-fold through a post-transcriptional mechanism mediated by E6 and E7 that was independent of the transcriptional downregulation mediated by HPV. In response to infection by vesicular stomatitis virus, phosphorylation of eIF2alpha was blocked in cells expressing HPV oncoproteins, but not in NHKs. Finally, it was observed that the cellular localization of PKR was altered by HPV gene products in HPV raft cultures, as well as HPV-positive patient biopsies. This effect was mediated by the HPV E6 oncoprotein and leads to the co-localization of PKR with P-bodies. These studies demonstrate that high-risk HPVs target the PKR pathway by multiple mechanisms.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17030851     DOI: 10.1099/vir.0.82098-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  39 in total

1.  Productive replication of human papillomavirus 31 requires DNA repair factor Nbs1.

Authors:  Daniel C Anacker; Dipendra Gautam; Kenric A Gillespie; William H Chappell; Cary A Moody
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

Review 2.  Tipping the balance: antagonism of PKR kinase and ADAR1 deaminase functions by virus gene products.

Authors:  Cyril X George; Zhiqun Li; Kristina M Okonski; Ann M Toth; Ying Wang; Charles E Samuel
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

3.  Unraveling regulation and new components of human P-bodies through a protein interaction framework and experimental validation.

Authors:  Dinghai Zheng; Chyi-Ying A Chen; Ann-Bin Shyu
Journal:  RNA       Date:  2011-07-12       Impact factor: 4.942

4.  The stress granule protein G3BP1 recruits protein kinase R to promote multiple innate immune antiviral responses.

Authors:  Lucas C Reineke; Richard E Lloyd
Journal:  J Virol       Date:  2014-12-17       Impact factor: 5.103

Review 5.  Early Defensive Mechanisms against Human Papillomavirus Infection.

Authors:  Andrea Moerman-Herzog; Mayumi Nakagawa
Journal:  Clin Vaccine Immunol       Date:  2015-06-10

6.  West Nile virus infection does not induce PKR activation in rodent cells.

Authors:  H Elbahesh; S V Scherbik; M A Brinton
Journal:  Virology       Date:  2011-10-07       Impact factor: 3.616

7.  Binding and relocalization of protein kinase R by murine cytomegalovirus.

Authors:  Stephanie J Child; Adam P Geballe
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

8.  Natural immune responses against eight oncogenic human papillomaviruses in the ASCUS-LSIL Triage Study.

Authors:  Lauren E Wilson; Michael Pawlita; Phillip E Castle; Tim Waterboer; Vikrant Sahasrabuddhe; Patti E Gravitt; Mark Schiffman; Nicolas Wentzensen
Journal:  Int J Cancer       Date:  2013-05-29       Impact factor: 7.396

9.  Inhibition of protein kinase R activation and upregulation of GADD34 expression play a synergistic role in facilitating coronavirus replication by maintaining de novo protein synthesis in virus-infected cells.

Authors:  Xiaoxing Wang; Ying Liao; Pei Ling Yap; Kim J Png; James P Tam; Ding Xiang Liu
Journal:  J Virol       Date:  2009-09-23       Impact factor: 5.103

10.  Cytoplasmic RNA Granules and Viral Infection.

Authors:  Wei-Chih Tsai; Richard E Lloyd
Journal:  Annu Rev Virol       Date:  2014-11       Impact factor: 10.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.